The matter surrounding Wockhardt's' codeine production practices has triggered a considerable controversy. Allegations surfaced suggesting possible data manipulation and insufficient oversight regarding the substance's production. This caused to regulatory scrutiny from the US Food and Drug Administration, culminating in production limitations a… Read More